EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel Marine‐Derived Phidiandine/Lipoic Acid Hybrid as a Potential Anti‐Atherosclerosis Agent: Design, Synthesis and in Vitro / in Vivo Evaluation

Shu-Jun Liu, Ying-Nan Zhong, Zhi-Qiang Cheng, Ning Meng, Juan Zhang, Cheng-Shi Jiang iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202301371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Shu-Jun Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Science and Technology, University of Jinan, Jinan, 250022, China. Hauptthemen laut MEDLINE: Thioctic Acid, Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Shandong Province Higher Educational Youth Innovation Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the present study, a novel derivative, IOP‐LA, was prepared by hybridizing antioxidant lipoic acid (LA) and our recently reported antioxidative marine phidianidine B‐inspired indole/1,2,4‐oxadiazole derivative. Our results demonstrated that IOP‐LA could protect vascular endothelial cells (VECs) from oxidized low‐density lipoprotein (oxLDL)‐induced oxidative stress by activating the Nrf2 pathway, inhibit the production of atherosclerotic plaque, and promote the stability of atherosclerotic plaque in apoE −/− mice. Moreover, the protective effect of IOP‐LA was superior to LA at the same concentration. Mechanistic studies revealed that IOP‐LA significantly inhibited the increase of reactive oxygen species (ROS) levels and the translocation of nuclear factor kappa‐B (NF‐κB) nuclear induced by oxLDL through the nuclear factor erythroid2‐related factor 2 (Nrf2) pathway. In summary, the data demonstrate that IOP‐LA, as a new antioxidant, protects VECs from oxLDL‐induced oxidative stress by activating the Nrf2 pathway. It is worth noting that this study provides a promising lead compound for the prevention and treatment of atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thioctic AcidPlaque, AtheroscleroticAtherosclerosisAnimalsMiceAntioxidantsNF-E2-Related Factor 2Endothelial Cells

Stichwörter der Autor:innen

Alpha-lipoic acidNrf2atherosclerosisphidianidine Bvascular endothelial cell

Substanzen

Thioctic AcidAntioxidantsNF-E2-Related Factor 2

Autor:innen und Institutionen

  • School of Biological Science and Technology, University of Jinan, Jinan, 250022, China.

ORCID-Profile: Cheng-Shi Jiang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Shandong Province Higher Educational Youth Innovation Science and Technology Program

Zitieren

APA

Liu, S. J., Zhong, Y. N., Cheng, Z. Q., Meng, N., Zhang, J., & Jiang, C. S. (2024). Discovery of Novel Marine‐Derived Phidiandine/Lipoic Acid Hybrid as a Potential Anti‐Atherosclerosis Agent: Design, Synthesis and in Vitro / in Vivo Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301371

Vancouver

Liu SJ, Zhong YN, Cheng ZQ, Meng N, Zhang J, Jiang CS. Discovery of Novel Marine‐Derived Phidiandine/Lipoic Acid Hybrid as a Potential Anti‐Atherosclerosis Agent: Design, Synthesis and in Vitro / in Vivo Evaluation. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301371

BibTeX
@article{Liu2024,
  author = {Liu, Shu-Jun and Zhong, Ying-Nan and Cheng, Zhi-Qiang and Meng, Ning and Zhang, Juan and Jiang, Cheng-Shi},
  title = {Discovery of Novel Marine‐Derived Phidiandine/Lipoic Acid Hybrid as a Potential Anti‐Atherosclerosis Agent: Design, Synthesis and in Vitro / in Vivo Evaluation},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202301371}
}
Kostenlos starten →